AKT1 and myeloproliferative disorder: To confirm our hypothesis that increased activation of the AKT-mTOR signalling pathway caused the MPD symptoms in CD11c LAMTOR2del mice, we treated the knockout and control animals with 30 μg Rapamycin for 10 days24, 25.